Targinta AB
559157-6698ActiveDeveloping targeted antibodies and ADCs for aggressive cancers.
Oversikt
- 0
- Ansatte
- ≤1t SEK
- Omsetning
- 2018
- Grunnlagt
Nøkkelbeslutningstakere
Evy Lundgren-Åkerlund
CSO
Beskrivelse
Targinta AB is a Swedish biotechnology company focused on developing novel treatments for aggressive and life-threatening cancers. The company specializes in creating targeted, toxin-armed antibodies, known as Antibody-Drug Conjugates (ADCs), and functional blocking antibodies. Their entire product...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE559157669801
Beslutningstakere
1 kontakter i FunnelfeedrEvy Lundgren-Åkerlund
CSO
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrXintela AB
10–19 ansatteDeveloping stem cell and targeted cancer therapies for unmet needs.
Ascelia Pharma AB
Biotech developing novel orphan oncology drugs for unmet needs.
BioInvent International Aktiebolag
100–199 ansatteClinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
Ascelia Incentive AB
Biotech developing novel orphan oncology drugs for unmet medical needs.
Affibody Medical AB
Developing next-generation radiopharmaceuticals using proprietary Affibody platform.
Utforsk mer
Spørsmål om Targinta AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo